Skip to main content
. 2002 Nov;161(5):1903–1915. doi: 10.1016/S0002-9440(10)64466-5

Table 3.

Effect of Intraperitoneal Injection of PAR-2 Agonists on MPO Activity and Microscopic Damage Score (Mean ± SEM; n = 8)

MPO (U/mg of protein) Microscopic damage score
A
    SLIGRL-NH2 (μg/mice)
40 201.3 ± 23.1 0.5 ± 0.12
100 159.2 ± 12.7 0.8 ± 0.10
400 181.2 ± 21.3 0.4 ± 0.17
        LRGILS-NH2 400 μg 148.2 ± 30.7 0.5 ± 0.23
B
    Time after SLIGRL-NH2 (100 μg/mice) administration
        4 (h) 132.1 ± 11.2 0.9 ± 0.21
        6 (h) 155.5 ± 62.74 0.5 ± 0.09
        8 (h) 192.4 ± 36.61 0.3 ± 0.06
        10 (h) 140.9 ± 75.66 0.7 ± 0.11